Baxter
BAX
#956
Rank
NZ$32.12 B
Marketcap
$62.97
Share price
0.36%
Change (1 day)
-4.86%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

Baxter (BAX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : NZ$30.07 B

According to Baxter's latest financial reports the company's total liabilities are NZ$30.07 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Baxter - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$31.32 B-11.19%
2022-12-31NZ$35.26 B-1.01%
2021-12-31NZ$35.62 B126.9%
2020-12-31NZ$15.70 B3.03%
2019-12-31NZ$15.24 B30.23%
2018-12-31NZ$11.70 B3.96%
2017-12-31NZ$11.25 B7.32%
2016-12-31NZ$10.48 B-40.72%
2015-12-31NZ$17.69 B-22.81%
2014-12-31NZ$22.92 B12.47%
2013-12-31NZ$20.38 B24.58%
2012-12-31NZ$16.35 B4.27%
2011-12-31NZ$15.68 B12.75%
2010-12-31NZ$13.91 B1%
2009-12-31NZ$13.77 B-13.38%
2008-12-31NZ$15.90 B46.7%
2007-12-31NZ$10.84 B-9.22%
2006-12-31NZ$11.94 B-3.14%
2005-12-31NZ$12.33 B-15.74%
2004-12-31NZ$14.63 B-8.82%
2003-12-31NZ$16.04 B-11.95%
2002-12-31NZ$18.22 B14.92%
2001-12-31NZ$15.86 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$78.12 B 159.80%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$31.30 B 4.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$26.66 B-11.31%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$48.02 B 59.71%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.71 B-90.97%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$82.37 B 173.92%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$7.18 B-76.12%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$63.94 B 112.65%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
NZ$3.63 B-87.91%๐Ÿ‡บ๐Ÿ‡ธ USA